Pedro Casariego Cerdeira

Pedro Casariego Cerdeira is a Research Associate at Rgenta Therapeutics Inc. since March 2022, focusing on small-molecule RNA-targeted therapies for oncological and neurodegenerative disorders. Previously, from September 2019 to January 2022, Pedro served as an Undergraduate Research Assistant at Boston University. Pedro earned a Bachelor's degree in Biochemistry and Molecular Biology and a Master of Arts in Biotechnology from Boston University, completing these degrees between 2017 and 2022.